JPMORGAN CHASE & CO - INTERSECT ENT INC ownership

INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 132 filers reported holding INTERSECT ENT INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of INTERSECT ENT INC
ValueSharesWeighting
Q1 2022$8,204,000
+4.1%
292,931
+1.5%
0.00%0.0%
Q4 2021$7,880,000
-16.9%
288,549
-17.2%
0.00%0.0%
Q3 2021$9,482,000
+773.1%
348,591
+448.5%
0.00%
Q2 2021$1,086,000
-81.7%
63,553
-77.6%
0.00%
-100.0%
Q1 2021$5,921,000
-24.3%
283,539
-17.0%
0.00%0.0%
Q4 2020$7,821,000
+18.1%
341,509
-15.3%
0.00%0.0%
Q3 2020$6,625,000
+23.2%
403,009
+1.4%
0.00%0.0%
Q2 2020$5,379,000
+33.8%
397,286
+17.1%
0.00%0.0%
Q1 2020$4,020,000
+1107.2%
339,274
+2439.1%
0.00%
Q4 2019$333,000
+57.8%
13,362
+7.7%
0.00%
Q3 2019$211,000
-62.9%
12,410
-50.2%
0.00%
Q2 2019$568,000
-46.0%
24,930
-23.7%
0.00%
Q1 2019$1,051,000
+23.6%
32,687
+8.3%
0.00%
Q4 2018$850,000
+168.1%
30,194
+173.8%
0.00%
Q3 2018$317,000
-28.6%
11,027
-7.1%
0.00%
Q2 2018$444,000
+71.4%
11,868
+79.3%
0.00%
Q1 2018$259,000
+37.0%
6,618
+13.7%
0.00%
Q4 2017$189,000
+2000.0%
5,820
+1866.2%
0.00%
Q3 2017$9,000
-99.6%
296
-99.6%
0.00%
Q2 2017$2,114,000
+1074.4%
75,632
+620.7%
0.00%
Q1 2017$180,000
-48.1%
10,494
-63.4%
0.00%
Q4 2016$347,000
-82.3%
28,672
-76.8%
0.00%
Q3 2016$1,960,000
+3.4%
123,748
-15.6%
0.00%
Q2 2016$1,896,000
-38.3%
146,649
-9.4%
0.00%
-100.0%
Q1 2016$3,074,000
-21.4%
161,784
-6.9%
0.00%0.0%
Q4 2015$3,912,000
-39.9%
173,854
-37.5%
0.00%
-50.0%
Q3 2015$6,507,000
+19.8%
278,087
+46.6%
0.00%
+100.0%
Q2 2015$5,432,000
-28.4%
189,742
-35.4%
0.00%
-50.0%
Q1 2015$7,590,000
+1797.5%
293,840
+1261.9%
0.00%
Q4 2014$400,000
-73.2%
21,576
-77.6%
0.00%
Q3 2014$1,490,00096,1720.00%
Other shareholders

There were no reported owners of INTERSECT ENT INC in Q1 2022.

NameSharesValueWeighting ↓
View complete list of INTERSECT ENT INC shareholders